Publication | Closed Access
Chemokine receptor CXCR7 is an independent prognostic biomarker in glioblastoma
25
Citations
22
References
2017
Year
CXCR7 may involve in the clinical GBM progression, and CXCR7 could be a valuable prognostic marker in the treatment of GBM.
| Year | Citations | |
|---|---|---|
Page 1
Page 1